Last reviewed · How we verify
metformin and chemotherapy
metformin and chemotherapy is a Small molecule drug developed by Peking University. It is currently in Phase 2 development.
At a glance
| Generic name | metformin and chemotherapy |
|---|---|
| Sponsor | Peking University |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Flatulence
- Urinary tract infection
Key clinical trials
- Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (PHASE2)
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy (PHASE4)
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (PHASE1, PHASE2)
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (PHASE2)
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity (PHASE2)
- Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia (PHASE2)
- Metformin vs Inositol vs Diet vs Combination Therapy in PCOS (NA)
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- metformin and chemotherapy CI brief — competitive landscape report
- metformin and chemotherapy updates RSS · CI watch RSS
- Peking University portfolio CI
Frequently asked questions about metformin and chemotherapy
What is metformin and chemotherapy?
metformin and chemotherapy is a Small molecule drug developed by Peking University.
Who makes metformin and chemotherapy?
metformin and chemotherapy is developed by Peking University (see full Peking University pipeline at /company/peking-university).
What development phase is metformin and chemotherapy in?
metformin and chemotherapy is in Phase 2.
What are the side effects of metformin and chemotherapy?
Common side effects of metformin and chemotherapy include Flatulence, Urinary tract infection.
Related
- Manufacturer: Peking University — full pipeline
- Compare: metformin and chemotherapy vs similar drugs
- Pricing: metformin and chemotherapy cost, discount & access